List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 7 studies with search of:   "Henogen" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule
Condition: Hepatitis B
Interventions: Biological: Adjuvanted Hepatitis B vaccine Lot 1;   Biological: Adjuvanted Hepatitis B vaccine Lot 2;   Biological: Adjuvanted Hep B vaccine Lot 3
2 Completed Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
Condition: Epstein Barr Virus (EBV) Infection
Intervention: Biological: EBV vaccine (268664)
3 Completed A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
Condition: Hepatitis B
Interventions: Biological: Henogen HBV vaccine;   Biological: FENDRIX
4 Completed Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
Condition: Hepatitis B
Interventions: Biological: HB-AS02V;   Biological: HBVAXPRO vaccine
5 Completed A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
Condition: Hepatitis B
Interventions: Biological: HB-AS02V vaccine;   Biological: HBVAXPRO vaccine
6 Active, not recruiting Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
Condition: Hepatitis B
Interventions: Biological: Henogen HB vaccine;   Biological: Fendrix vaccine
7 Not yet recruiting Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease
Intervention: Biological: IT-Combination

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services